ACRS vs CHRW · rev $3.6M vs P/E 37, rev $8.95B
Aclaris Therapeutics Inc (ACRS) versus CH Robinson Worldwide Inc (CHRW) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
CH Robinson Worldwide Inc (CHRW) is a integrated freight & logistics company listed on US.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
Latest reported CHRW revenue for 2026-06-30 was $8.95B. Net income was $334.0M. CHRW currently screens at market cap $21.70B and trailing P/E 37.3.
ACRS currently screens at market cap $615.9M. CHRW currently screens at market cap $21.70B and trailing P/E 37.3.
Not investment advice. Open the ACRS and CHRW stock pages for the full models.
Not investment advice.